U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 353

1.
SERPINA5 inhibits tumor cell migration by modulating the fibronectin‐integrin β1 signaling pathway in hepatocellular carcinoma
Ying Jing, Deshui Jia, Chun-Ming Wong, Irene Oi-Lin Ng, Zhenfeng Zhang, Li Liu, Qifeng Wang, Fangyu Zhao, Jinjun Li, Ming Yao, Xingzhong Wu, Xianghuo He
Mol Oncol. 2014 Mar; 8(2): 366–377. Published online 2013 Dec 18. doi: 10.1016/j.molonc.2013.12.003
PMCID:
PMC5528558
AbstractArticlePDF–2.0M
2.
Tumour suppressor gene (CDKNA2) status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer
Ismail El-Mokadem, Thomas Kidd, Norman Pratt, Stewart Fleming, Ghulam Nabi
Oncotarget. 2016 Nov 8; 7(45): 73045–73054. Published online 2016 Sep 22. doi: 10.18632/oncotarget.12196
PMCID:
PMC5341962
AbstractArticlePDF–972K
3.
Dot1l expression predicts adverse postoperative prognosis of patients with clear-cell renal cell carcinoma
Yang Qu, Li Liu, Jiajun Wang, Wei Xi, Yu Xia, Qi Bai, Ying Xiong, Qilai Long, Jiejie Xu, Jianming Guo
Oncotarget. 2016 Dec 20; 7(51): 84775–84784. Published online 2016 Oct 5. doi: 10.18632/oncotarget.12476
PMCID:
PMC5356697
AbstractArticlePDF–3.4M
4.
Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma
Madeleine Arseneault, Jean Monlong, Naveen S. Vasudev, Ruhina S. Laskar, Maryam Safisamghabadi, Patricia Harnden, Lars Egevad, Nazanin Nourbehesht, Pudchalaluck Panichnantakul, Ivana Holcatova, Antonin Brisuda, Vladimir Janout, Helena Kollarova, Lenka Foretova, Marie Navratilova, Dana Mates, Viorel Jinga, David Zaridze, Anush Mukeria, Pouria Jandaghi, Paul Brennan, Alvis Brazma, Jorg Tost, Ghislaine Scelo, Rosamonde E. Banks, Mark Lathrop, Guillaume Bourque, Yasser Riazalhosseini
Sci Rep. 2017; 7: 44876. Published online 2017 Mar 23. doi: 10.1038/srep44876
PMCID:
PMC5362952
AbstractArticlePDF–916K
5.
RBM10-TFE3 renal cell carcinoma: A potential diagnostic pitfall due to cryptic intrachromosomal Xp11.2 inversion resulting in false-negative TFE3 FISH
Pedram Argani, Lei Zhang, Victor E. Reuter, Satish K. Tickoo, Cristina R. Antonescu
Am J Surg Pathol. Author manuscript; available in PMC 2018 May 1.
Published in final edited form as: Am J Surg Pathol. 2017 May; 41(5): 655–662. doi: 10.1097/PAS.0000000000000835
PMCID:
PMC5391276
AbstractArticlePDF–1.9M
6.
Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis
H.-J. Thiesen, F. Steinbeck, M. Maruschke, D. Koczan, B. Ziems, O. W. Hakenberg
PLoS One. 2017; 12(5): e0176659. Published online 2017 May 9. doi: 10.1371/journal.pone.0176659
PMCID:
PMC5423597
AbstractArticlePDF–6.7M
7.
Characterization of a splice-site mutation in the tumor suppressor gene FLCN associated with renal cancer
Malte P. Bartram, Tripti Mishra, Nadine Reintjes, Francesca Fabretti, Hakam Gharbi, Alexander C. Adam, Heike Göbel, Mareike Franke, Bernhard Schermer, Stefan Haneder, Thomas Benzing, Bodo B. Beck, Roman-Ulrich Müller
BMC Med Genet. 2017; 18: 53. Published online 2017 May 12. doi: 10.1186/s12881-017-0416-5
PMCID:
PMC5429543
AbstractArticlePDF–3.8M
8.
CD146 Promoter Polymorphism (rs3923594) Is Associated with Recurrence of Clear Cell Renal Cell Carcinoma in Chinese Population
Gang Feng, Hou-Bao Huang, Xiao-Bing Ye, Peng Zhang, Jian-Jun Huang, Li-Zhu Huang, Long Cheng, Chun Pu, Guorong Li
Dis Markers. 2017; 2017: 2543059. Published online 2017 May 24. doi: 10.1155/2017/2543059
PMCID:
PMC5463157
AbstractArticlePDF–675K
9.
Renal cell carcinoma harboring somatic TSC2 mutations in a child with methylmalonic acidemia
Samara L. Potter, Rajkumar Venkatramani, Scott Wenderfer, Brett H. Graham, Sanjeev A. Vasudevan, Andrew Sher, Hao Wu, David A. Wheeler, Yaping Yang, Christine M. Eng, Richard A. Gibbs, Angshumoy Roy, Sharon E. Plon, D. Williams Parsons
Pediatr Blood Cancer. Author manuscript; available in PMC 2017 Jun 13.
Published in final edited form as: Pediatr Blood Cancer. 2017 May; 64(5): 10.1002/pbc.26286. Published online 2016 Oct 17. doi: 10.1002/pbc.26286
PMCID:
PMC5469213
AbstractArticlePDF–294K
10.
Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical Evaluation
Aristotle Bamias, Bernard Escudier, Cora N. Sternberg, Flora Zagouri, Athanasios Dellis, Bob Djavan, Kimon Tzannis, Loukas Kontovinis, Konstantinos Stravodimos, Athanasios Papatsoris, Dionysios Mitropoulos, Charalampos Deliveliotis, Meletios‐Athanasios Dimopoulos, Constantine A. Constantinides
Oncologist. 2017 Jun; 22(6): 667–679. Published online 2017 Jun 7. doi: 10.1634/theoncologist.2016-0435
PMCID:
PMC5469586
AbstractArticlePDF–379K
11.
ProEx C as Diagnostic Marker for Detection of Urothelial Carcinoma in Urinary Samples: A Review
Gerardo Botti, Maria Gabriella Malzone, Elvira La Mantia, Micaela Montanari, Daniela Vanacore, Sabrina Rossetti, Vincenzo Quagliariello, Carla Cavaliere, Rossella Di Franco, Luigi Castaldo, Gianluca Ametrano, Francesca Cappuccio, Francesco Jacopo Romano, Raffaele Piscitelli, Maria Filomena Pepe, Carmine D'Aniello, Gaetano Facchini
Int J Med Sci. 2017; 14(6): 554–559. Published online 2017 Apr 21. doi: 10.7150/ijms.17890
PMCID:
PMC5479124
AbstractArticlePDF–785K
12.
High CLEC-2 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma
Ying Xiong, Li Liu, Yu Xia, Jiajun Wang, Wei Xi, Qi Bai, Yang Qu, Qilai Long, Jiejie Xu, Jianming Guo
Oncotarget. 2016 Sep 27; 7(39): 63661–63668. Published online 2016 Aug 25. doi: 10.18632/oncotarget.11606
PMCID:
PMC5325393
AbstractArticlePDF–4.6M
13.
Genomic Alterations as Predictors of Survival Among Patients within a Combined Cohort with Clear Cell Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy
Daniel M. Tennenbaum, Brandon J. Manley, Emily Zabor, Maria F. Becerra, Maria I. Carlo, Jozefina Casuscelli, Almedina Redzematovic, Nabeela Khan, Maria E. Arcila, Martin H. Voss, Darren R. Feldman, Robert J. Motzer, Nicole E. Benfante, Jonathan A. Coleman, Paul Russo, James J. Hsieh, A. Ari Hakimi
Urol Oncol. Author manuscript; available in PMC 2018 Aug 1.
Published in final edited form as: Urol Oncol. 2017 Aug; 35(8): 532.e7–532.e13. Published online 2017 Apr 10. doi: 10.1016/j.urolonc.2017.03.015
PMCID:
PMC5545055
AbstractArticlePDF–421K
14.
IRF5 is associated with adverse postoperative prognosis of patients with non-metastatic clear cell renal cell carcinoma
Qi Bai, Li Liu, Yu Xia, Jiajun Wang, Wei Xi, Yang Qu, Ying Xiong, Qilai Long, Jiejie Xu, Jianming Guo
Oncotarget. 2017 Jul 4; 8(27): 44186–44194. Published online 2017 May 11. doi: 10.18632/oncotarget.17777
PMCID:
PMC5546472
AbstractArticlePDF–8.1M
15.
The Landscape of Whole-genome Alterations and Pathologic Features in Genitourinary Malignancies: An Analysis of the Cancer Genome Atlas
Mark W. Ball, Michael A. Gorin, Charles G. Drake, Hans J. Hammers, Mohamad E. Allaf
Eur Urol Focus. Author manuscript; available in PMC 2018 Dec 1.
Published in final edited form as: Eur Urol Focus. 2017 Dec; 3(6): 584–589. Published online 2017 Feb 8. doi: 10.1016/j.euf.2017.01.007
PMCID:
PMC5548653
AbstractArticlePDF–291K
16.
Expression of long non-coding RNA MFI2-AS1 is a strong predictor of recurrence in sporadic localized clear-cell renal cell carcinoma
Ronan Flippot, Roger Mouawad, Jean-Philippe Spano, Morgan Rouprêt, Eva Compérat, Marc-Olivier Bitker, Jérôme Parra, Christophe Vaessen, Frederick Allanic, Quentin Manach, Nizar M. Tannir, David Khayat, Xiaoping Su, Gabriel G. Malouf
Sci Rep. 2017; 7: 8540. Published online 2017 Aug 17. doi: 10.1038/s41598-017-08363-6
PMCID:
PMC5561098
AbstractArticlePDF–1.2M
17.
Prognostic significance of promoter CpG island methylation of obesity-related genes in non-metastatic renal cell carcinoma patients
Julia Mendoza-Pérez, Jian Gu, Luis A. Herrera, Nizar M. Tannir, Shanyu Zhang, Surena Matin, Jose A. Karam, Christopher G. Wood, Xifeng Wu
Cancer. Author manuscript; available in PMC 2018 Sep 15.
Published in final edited form as: Cancer. 2017 Sep 15; 123(18): 3617–3627. Published online 2017 May 23. doi: 10.1002/cncr.30707
PMCID:
PMC5589484
AbstractArticlePDF–563K
18.
Primary paranasal sinus hyalinizing clear cell carcinoma: a case report
Batool M. AlAli, Mohammed J. Alyousef, Ahmad Salah Kamel, Mohammad A. Al hamad, Mohammad H. Al-Bar, Roaa M. Algowiez
Diagn Pathol. 2017; 12: 70. Published online 2017 Sep 25. doi: 10.1186/s13000-017-0659-7
PMCID:
PMC5613526
AbstractArticlePDF–1.3M
19.
Postoperative recurrence of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion
Zhen Wang, Ning Liu, Weidong Gan, Xiaogong Li, Gutian Zhang, Dongmei Li, Hongqian Guo
J Int Med Res. 2017 Aug; 45(4): 1287–1296. Published online 2017 Jun 6. doi: 10.1177/0300060517711358
PMCID:
PMC5625541
AbstractArticlePDF–497K
20.
Increased expression of Fibrinogen-Like Protein 2 is associated with poor prognosis in patients with clear cell renal cell carcinoma
Ming Tang, Xu Cao, Peng Li, Kun Zhang, You Li, Quan-you Zheng, Gui-qing Li, Jian Chen, Gui-lian Xu, Ke-qin Zhang
Sci Rep. 2017; 7: 12676. Published online 2017 Oct 4. doi: 10.1038/s41598-017-13149-x
PMCID:
PMC5627263
AbstractArticlePDF–2.7M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center